Assessing Renal Function in Patients With an Antibiotic Laden Spacer

Nephrotoxicity Following 2-Stage Exchange With Associated Antibiotic Laden Spacer in Patients With Infected Total Hip/Knee Arthroplasty

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01683734

Enrollment

Registered

2012-09-12

Start date

2012-05-31

Completion date

Unknown

Last updated

2015-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infected Total Hip or Knee Arthroplasty

Brief summary

The purpose of this study is to monitor the renal function of patients who have an antibiotic laden spacer in place to treat an infected hip or knee arthroplasty.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. All patients undergoing a hip or knee resection arthroplasty by the primary investigator 2. Ages 18+ 3. Ability to adhere to follow up schedule

Exclusion criteria

1. Unable to give informed consent 2. Age \<18 3. Previous history of infected Total Knee Arthroplasty or Total Hip Arthroplasty 4. History of renal failure or impaired renal function 5. Allergies to aminoglycosides or Vancomycin

Design outcomes

Primary

Measure	Time frame
Development of acute renal insufficiency or acute renal failure measured by changes in laboratory values assessing renal function	subjects will be followed during the time the antibiotic spacer is in place which is approximately 8 weeks

Countries

United States

Contacts

Primary ContactStefanie Miller, BS

Stefanie.Miller@CadenceHealth.org630-933-6254

Backup ContactJudy Guerreiro, RN

Judy.Guerreiro@CadenceHealth.org630-933-2941

Outcome results